Re: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
by Elizabeth Tilley
Thank you!
From: Lori Schultz <lori.schultz(a)utsa.edu>
Sent: Friday, February 28, 2025 12:24 PM
To: Elizabeth Tilley <elizabeth.tilley(a)utsa.edu>; rowdy.research(a)lists.it.utsa.edu
Cc: Guoquan Zhang <guoquan.zhang(a)utsa.edu>
Subject: Re: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Thanks, Liz!
I don’t have any additional context about how & when we will have more information on when study sections will be rescheduled. The issue of not being able to post in the Federal Register is complicating things. If I learn more, I will let you all know.
From: Elizabeth Tilley <elizabeth.tilley(a)utsa.edu<mailto:elizabeth.tilley@utsa.edu>>
Date: Friday, February 28, 2025 at 12:21 PM
To: rowdy.research(a)lists.it.utsa.edu<mailto:rowdy.research@lists.it.utsa.edu> <rowdy.research(a)lists.it.utsa.edu<mailto:rowdy.research@lists.it.utsa.edu>>
Cc: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Subject: [Rowdy.research] FW: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Good afternoon, Everyone,
I just wanted to forward a message from NIH program officer regarding certain study section reviews. It’s kind of what we would expect. Meetings that were scheduled yesterday did not occur. NIH cannot give a date to when study section reviews will occur.
Thanks
From: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Sent: Friday, February 28, 2025 9:36 AM
To: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Subject: RE: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Dear Dr. Zhang,
The IHD meeting will be rescheduled for a later date, yet to be determined. I have no further information at this time. You’ll receive notification via eRA Commons when the status of your application changes.
Thank you,
Alok
====
Alok Mulky, Ph.D.
Scientific Review Officer, Immunity and Host Defense (IHD)
Assistant Research/Review Integrity Officer (RIO)
Center for Scientific Review (CSR)
National Institutes of Health (NIH)
6701 Rockledge Dr.
Bethesda, MD 20817
Phone: (301) 435-3566
Fax: (301) 480-4042
Email: alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>
Fairness matters. Say something! For possible violations of peer review integrity, contact your Scientific Review Officer (SRO), the CSR Review Integrity Officer at csrrio(a)mail.nih.gov<mailto:csrrio@mail.nih.gov> or the NIH Review Policy Officer at reviewpolicyofficer(a)mail.nih.gov<mailto:reviewpolicyofficer@mail.nih.gov>. For issues related to respectful interactions, bias or anything else that could affect the fairness of the review process, contact your SRO or send a message to reportconcern(a)csr.nih.gov<mailto:reportconcern@csr.nih.gov>
Alert: For due dates on or after Jan 25, 2025 - changes coming to how most research grant applications will be reviewed. Learn about the new simplified review framework<https://grants.nih.gov/policy/peer/simplifying-review.htm>.
From: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Sent: Friday, February 28, 2025 10:26 AM
To: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Subject: Re: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Good morning Dr. Mulky and I hope this email finds you well. While I learned from your website that [cid:image001.png@01DB89E0.08B04150] and am wondering if you have an update on the meeting time.
Thanks,
Guoquan
________________________________
From: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Sent: Thursday, January 9, 2025 11:51 AM
To: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Subject: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
**EXTERNAL EMAIL**
This email originated outside of The University of Texas at San Antonio.
Please exercise caution when clicking on links or opening attachments.
Dear Dr. Zhang,
The NIH has received your grant application entitled “The role of CCR10 in regulating mucosal IgA response against Coxiella burnetii infection,” application number 1 R21 AI188471-01A1 and assigned it to the Immunity and Host Defense (IHD) Study Section for review. As the Scientific Review Officer for this study section, I will be your primary NIH contact before the review. This email answers several questions you may have.
When will I hear about the review?
• This study section will meet on February 27-28, 2025.
• Results will be available through NIH Commons.
– Priority scores by March 5, 2025.
– Summary statements will be released by March 30, 2025.
May I submit changes or supplements to my application?
You may submit:
• notification that an article has been accepted for publication.
• some other changes, for example, if a natural disaster affects your application or you must change a senior / key person on the application.
Details of this policy: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-083.html
You may also submit for applications submitted for the May 2025 council (2025/05):
• Regarding the one-page update with preliminary data: For applications submitted for the May 25, 2023 receipt date and beyond, the one-page update with preliminary data will only be accepted if (1) it is for Type 1 (New and Resubmission of application) R01, R21, or R03 applications, and (2) if the NOFO used for submission allows preliminary data in the application.
Policy Details: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-23-106.html
If you have an acceptable change or supplement, I must receive it at least 30 calendar days before the study section meeting (Deadline for receipt: January 28, 2025) from your organization's Authorized Organization Representative (AOR) or Signing Official (SO) as a PDF attachment to an email.
*Material sent directly by the PI without AOR/SO concurrence WILL NOT be accepted*
If your application is a multi-PI application, please coordinate your supplementary materials and have your AOR/SO send them as a single document to me. Please include e-mail addresses of all the PIs and I will respond to all to acknowledge receipt of materials.
May I speak to a reviewer?
NO! Neither you nor anyone on your behalf may contact the Chairperson or other Members on the IHD Study Section Meeting Roster about any aspect of the review of your application before, during, or after the study section meeting. Contacting a study section member violates NIH confidentiality and conflict of interest rules. It could lead to a deferral of your application.
Reviewers sign a legal document stating that they will not discuss anything about the review of any application with anyone outside the formal sessions of the study section meeting.
If you have questions
Before the study section meeting, contact me.
After the study section meeting, contact your Program Officer (PO) at the institute that is considering your application for funding. You will find your PO’s name in your NIH Commons account in association with your application.
Do not hesitate to contact me with any questions regarding the review process.
Best regards,
Alok Mulky
====
Alok Mulky, Ph.D.
Scientific Review Officer, Immunity and Host Defense (IHD)
Assistant Research/Review Integrity Officer (RIO)
Center for Scientific Review (CSR)
National Institutes of Health (NIH)
6701 Rockledge Dr.
Bethesda, MD 20817
Phone: (301) 435-3566
Fax: (301) 480-4042
Email: alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>
Fairness matters. Say something! For possible violations of peer review integrity, contact your Scientific Review Officer (SRO), the CSR Review Integrity Officer at csrrio(a)mail.nih.gov<mailto:csrrio@mail.nih.gov> or the NIH Review Policy Officer at reviewpolicyofficer(a)mail.nih.gov<mailto:reviewpolicyofficer@mail.nih.gov>. For issues related to respectful interactions, bias or anything else that could affect the fairness of the review process, contact your SRO or send a message to reportbias(a)csr.nih.gov<mailto:reportbias@csr.nih.gov>
Alert: For due dates on or after Jan 25, 2025 - changes coming to how most research grant applications will be reviewed. Learn about the new simplified review framework<https://grants.nih.gov/policy/peer/simplifying-review.htm>.
CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and are confident the content is safe.
1 year
Re: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
by Lori Schultz
Thanks, Liz!
I don’t have any additional context about how & when we will have more information on when study sections will be rescheduled. The issue of not being able to post in the Federal Register is complicating things. If I learn more, I will let you all know.
From: Elizabeth Tilley <elizabeth.tilley(a)utsa.edu>
Date: Friday, February 28, 2025 at 12:21 PM
To: rowdy.research(a)lists.it.utsa.edu <rowdy.research(a)lists.it.utsa.edu>
Cc: Guoquan Zhang <guoquan.zhang(a)utsa.edu>
Subject: [Rowdy.research] FW: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Good afternoon, Everyone,
I just wanted to forward a message from NIH program officer regarding certain study section reviews. It’s kind of what we would expect. Meetings that were scheduled yesterday did not occur. NIH cannot give a date to when study section reviews will occur.
Thanks
From: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Sent: Friday, February 28, 2025 9:36 AM
To: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Subject: RE: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Dear Dr. Zhang,
The IHD meeting will be rescheduled for a later date, yet to be determined. I have no further information at this time. You’ll receive notification via eRA Commons when the status of your application changes.
Thank you,
Alok
====
Alok Mulky, Ph.D.
Scientific Review Officer, Immunity and Host Defense (IHD)
Assistant Research/Review Integrity Officer (RIO)
Center for Scientific Review (CSR)
National Institutes of Health (NIH)
6701 Rockledge Dr.
Bethesda, MD 20817
Phone: (301) 435-3566
Fax: (301) 480-4042
Email: alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>
Fairness matters. Say something! For possible violations of peer review integrity, contact your Scientific Review Officer (SRO), the CSR Review Integrity Officer at csrrio(a)mail.nih.gov<mailto:csrrio@mail.nih.gov> or the NIH Review Policy Officer at reviewpolicyofficer(a)mail.nih.gov<mailto:reviewpolicyofficer@mail.nih.gov>. For issues related to respectful interactions, bias or anything else that could affect the fairness of the review process, contact your SRO or send a message to reportconcern(a)csr.nih.gov<mailto:reportconcern@csr.nih.gov>
Alert: For due dates on or after Jan 25, 2025 - changes coming to how most research grant applications will be reviewed. Learn about the new simplified review framework<https://grants.nih.gov/policy/peer/simplifying-review.htm>.
From: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Sent: Friday, February 28, 2025 10:26 AM
To: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Subject: Re: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Good morning Dr. Mulky and I hope this email finds you well. While I learned from your website that [cid:image001.png@01DB89D3.DE2E1B70] and am wondering if you have an update on the meeting time.
Thanks,
Guoquan
________________________________
From: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Sent: Thursday, January 9, 2025 11:51 AM
To: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Subject: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
**EXTERNAL EMAIL**
This email originated outside of The University of Texas at San Antonio.
Please exercise caution when clicking on links or opening attachments.
Dear Dr. Zhang,
The NIH has received your grant application entitled “The role of CCR10 in regulating mucosal IgA response against Coxiella burnetii infection,” application number 1 R21 AI188471-01A1 and assigned it to the Immunity and Host Defense (IHD) Study Section for review. As the Scientific Review Officer for this study section, I will be your primary NIH contact before the review. This email answers several questions you may have.
When will I hear about the review?
• This study section will meet on February 27-28, 2025.
• Results will be available through NIH Commons.
– Priority scores by March 5, 2025.
– Summary statements will be released by March 30, 2025.
May I submit changes or supplements to my application?
You may submit:
• notification that an article has been accepted for publication.
• some other changes, for example, if a natural disaster affects your application or you must change a senior / key person on the application.
Details of this policy: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-083.html
You may also submit for applications submitted for the May 2025 council (2025/05):
• Regarding the one-page update with preliminary data: For applications submitted for the May 25, 2023 receipt date and beyond, the one-page update with preliminary data will only be accepted if (1) it is for Type 1 (New and Resubmission of application) R01, R21, or R03 applications, and (2) if the NOFO used for submission allows preliminary data in the application.
Policy Details: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-23-106.html
If you have an acceptable change or supplement, I must receive it at least 30 calendar days before the study section meeting (Deadline for receipt: January 28, 2025) from your organization's Authorized Organization Representative (AOR) or Signing Official (SO) as a PDF attachment to an email.
*Material sent directly by the PI without AOR/SO concurrence WILL NOT be accepted*
If your application is a multi-PI application, please coordinate your supplementary materials and have your AOR/SO send them as a single document to me. Please include e-mail addresses of all the PIs and I will respond to all to acknowledge receipt of materials.
May I speak to a reviewer?
NO! Neither you nor anyone on your behalf may contact the Chairperson or other Members on the IHD Study Section Meeting Roster about any aspect of the review of your application before, during, or after the study section meeting. Contacting a study section member violates NIH confidentiality and conflict of interest rules. It could lead to a deferral of your application.
Reviewers sign a legal document stating that they will not discuss anything about the review of any application with anyone outside the formal sessions of the study section meeting.
If you have questions
Before the study section meeting, contact me.
After the study section meeting, contact your Program Officer (PO) at the institute that is considering your application for funding. You will find your PO’s name in your NIH Commons account in association with your application.
Do not hesitate to contact me with any questions regarding the review process.
Best regards,
Alok Mulky
====
Alok Mulky, Ph.D.
Scientific Review Officer, Immunity and Host Defense (IHD)
Assistant Research/Review Integrity Officer (RIO)
Center for Scientific Review (CSR)
National Institutes of Health (NIH)
6701 Rockledge Dr.
Bethesda, MD 20817
Phone: (301) 435-3566
Fax: (301) 480-4042
Email: alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>
Fairness matters. Say something! For possible violations of peer review integrity, contact your Scientific Review Officer (SRO), the CSR Review Integrity Officer at csrrio(a)mail.nih.gov<mailto:csrrio@mail.nih.gov> or the NIH Review Policy Officer at reviewpolicyofficer(a)mail.nih.gov<mailto:reviewpolicyofficer@mail.nih.gov>. For issues related to respectful interactions, bias or anything else that could affect the fairness of the review process, contact your SRO or send a message to reportbias(a)csr.nih.gov<mailto:reportbias@csr.nih.gov>
Alert: For due dates on or after Jan 25, 2025 - changes coming to how most research grant applications will be reviewed. Learn about the new simplified review framework<https://grants.nih.gov/policy/peer/simplifying-review.htm>.
CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and are confident the content is safe.
1 year
FW: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
by Elizabeth Tilley
Good afternoon, Everyone,
I just wanted to forward a message from NIH program officer regarding certain study section reviews. It's kind of what we would expect. Meetings that were scheduled yesterday did not occur. NIH cannot give a date to when study section reviews will occur.
Thanks
From: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Sent: Friday, February 28, 2025 9:36 AM
To: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Subject: RE: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Dear Dr. Zhang,
The IHD meeting will be rescheduled for a later date, yet to be determined. I have no further information at this time. You'll receive notification via eRA Commons when the status of your application changes.
Thank you,
Alok
====
Alok Mulky, Ph.D.
Scientific Review Officer, Immunity and Host Defense (IHD)
Assistant Research/Review Integrity Officer (RIO)
Center for Scientific Review (CSR)
National Institutes of Health (NIH)
6701 Rockledge Dr.
Bethesda, MD 20817
Phone: (301) 435-3566
Fax: (301) 480-4042
Email: alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>
Fairness matters. Say something! For possible violations of peer review integrity, contact your Scientific Review Officer (SRO), the CSR Review Integrity Officer at csrrio(a)mail.nih.gov<mailto:csrrio@mail.nih.gov> or the NIH Review Policy Officer at reviewpolicyofficer(a)mail.nih.gov<mailto:reviewpolicyofficer@mail.nih.gov>. For issues related to respectful interactions, bias or anything else that could affect the fairness of the review process, contact your SRO or send a message to reportconcern(a)csr.nih.gov<mailto:reportconcern@csr.nih.gov>
Alert: For due dates on or after Jan 25, 2025 - changes coming to how most research grant applications will be reviewed. Learn about the new simplified review framework<https://grants.nih.gov/policy/peer/simplifying-review.htm>.
From: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Sent: Friday, February 28, 2025 10:26 AM
To: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Subject: Re: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
Good morning Dr. Mulky and I hope this email finds you well. While I learned from your website that [cid:image001.png@01DB89D3.DE2E1B70] and am wondering if you have an update on the meeting time.
Thanks,
Guoquan
________________________________
From: Mulky, Alok (NIH/CSR) [E] <alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>>
Sent: Thursday, January 9, 2025 11:51 AM
To: Guoquan Zhang <guoquan.zhang(a)utsa.edu<mailto:guoquan.zhang@utsa.edu>>
Subject: [EXTERNAL] Notice of Application Assignment to the IHD Study Section for 2025/05 Council
**EXTERNAL EMAIL**
This email originated outside of The University of Texas at San Antonio.
Please exercise caution when clicking on links or opening attachments.
Dear Dr. Zhang,
The NIH has received your grant application entitled "The role of CCR10 in regulating mucosal IgA response against Coxiella burnetii infection," application number 1 R21 AI188471-01A1 and assigned it to the Immunity and Host Defense (IHD) Study Section for review. As the Scientific Review Officer for this study section, I will be your primary NIH contact before the review. This email answers several questions you may have.
When will I hear about the review?
* This study section will meet on February 27-28, 2025.
* Results will be available through NIH Commons.
- Priority scores by March 5, 2025.
- Summary statements will be released by March 30, 2025.
May I submit changes or supplements to my application?
You may submit:
* notification that an article has been accepted for publication.
* some other changes, for example, if a natural disaster affects your application or you must change a senior / key person on the application.
Details of this policy: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-083.html
You may also submit for applications submitted for the May 2025 council (2025/05):
* Regarding the one-page update with preliminary data: For applications submitted for the May 25, 2023 receipt date and beyond, the one-page update with preliminary data will only be accepted if (1) it is for Type 1 (New and Resubmission of application) R01, R21, or R03 applications, and (2) if the NOFO used for submission allows preliminary data in the application.
Policy Details: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-23-106.html
If you have an acceptable change or supplement, I must receive it at least 30 calendar days before the study section meeting (Deadline for receipt: January 28, 2025) from your organization's Authorized Organization Representative (AOR) or Signing Official (SO) as a PDF attachment to an email.
*Material sent directly by the PI without AOR/SO concurrence WILL NOT be accepted*
If your application is a multi-PI application, please coordinate your supplementary materials and have your AOR/SO send them as a single document to me. Please include e-mail addresses of all the PIs and I will respond to all to acknowledge receipt of materials.
May I speak to a reviewer?
NO! Neither you nor anyone on your behalf may contact the Chairperson or other Members on the IHD Study Section Meeting Roster about any aspect of the review of your application before, during, or after the study section meeting. Contacting a study section member violates NIH confidentiality and conflict of interest rules. It could lead to a deferral of your application.
Reviewers sign a legal document stating that they will not discuss anything about the review of any application with anyone outside the formal sessions of the study section meeting.
If you have questions
Before the study section meeting, contact me.
After the study section meeting, contact your Program Officer (PO) at the institute that is considering your application for funding. You will find your PO's name in your NIH Commons account in association with your application.
Do not hesitate to contact me with any questions regarding the review process.
Best regards,
Alok Mulky
====
Alok Mulky, Ph.D.
Scientific Review Officer, Immunity and Host Defense (IHD)
Assistant Research/Review Integrity Officer (RIO)
Center for Scientific Review (CSR)
National Institutes of Health (NIH)
6701 Rockledge Dr.
Bethesda, MD 20817
Phone: (301) 435-3566
Fax: (301) 480-4042
Email: alok.mulky(a)nih.gov<mailto:alok.mulky@nih.gov>
Fairness matters. Say something! For possible violations of peer review integrity, contact your Scientific Review Officer (SRO), the CSR Review Integrity Officer at csrrio(a)mail.nih.gov<mailto:csrrio@mail.nih.gov> or the NIH Review Policy Officer at reviewpolicyofficer(a)mail.nih.gov<mailto:reviewpolicyofficer@mail.nih.gov>. For issues related to respectful interactions, bias or anything else that could affect the fairness of the review process, contact your SRO or send a message to reportbias(a)csr.nih.gov<mailto:reportbias@csr.nih.gov>
Alert: For due dates on or after Jan 25, 2025 - changes coming to how most research grant applications will be reviewed. Learn about the new simplified review framework<https://grants.nih.gov/policy/peer/simplifying-review.htm>.
CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and are confident the content is safe.
1 year
Re: FY26 budget template error- subaward indirect base calculation
by Jennifer Silver
Thanks, Liz! We'll get that fixed and reload the template.
Jennifer
From: Elizabeth Sandoval <elizabeth.sandoval(a)utsa.edu>
Sent: Friday, February 28, 2025 12:03 PM
To: rowdy.research(a)lists.it.utsa.edu
Subject: [Rowdy.research] FY26 budget template error- subaward indirect base calculation
There is an error on the FY26 budget template, period 2 affecting the total subaward portion under $50K. In my case, it added an additional $50K to the indirect cost base which created an error in the F&A calculation. I verified that the incorrect formula is not on any of the other periods or in the FY25 budget template.
[cid:image001.jpg@01DB89D9.64172AB0]
Current FY26, period 2 formula
[cid:image002.png@01DB89D9.64172AB0]
Copied fomula from the other periods.
[cid:image003.jpg@01DB89D9.64172AB0]
Elizabeth (Liz) Sandoval
Senior Research Administrator
The University of Texas at San Antonio
Carlos Alvarez College Of Business
elizabeth.sandoval(a)utsa.edu<mailto:jaime.guzman@utsa.edu>
[cid:image004.png@01DB89D9.64172AB0]
1 year
FY26 budget template error- subaward indirect base calculation
by Elizabeth Sandoval
There is an error on the FY26 budget template, period 2 affecting the total subaward portion under $50K. In my case, it added an additional $50K to the indirect cost base which created an error in the F&A calculation. I verified that the incorrect formula is not on any of the other periods or in the FY25 budget template.
[cid:image002.jpg@01DB89D8.AC4E8590]
Current FY26, period 2 formula
[cid:image003.png@01DB89D7.B5F83C40]
Copied fomula from the other periods.
[cid:image005.jpg@01DB89D8.AC4E8590]
Elizabeth (Liz) Sandoval
Senior Research Administrator
The University of Texas at San Antonio
Carlos Alvarez College Of Business
elizabeth.sandoval(a)utsa.edu<mailto:jaime.guzman@utsa.edu>
[cid:image006.png@01DB89D7.B5F83C40]
1 year
Updates on NIH Study Section Reviews
by Elizabeth Tilley
Hi All,
Has anyone received any information on the NIH study section reviews that were canceled this last week?
Please advise.
Thank you,
Liz
Elizabeth H. Escoto (formerly Tilley), PhD
Sr. Research Administrator
COS College Research Administration Teams
Office of Research
The University of Texas at San Antonio
cell: 347.299.1641
One UTSA Circle
San Antonio, TX 78249-3209
________________________________
1 year
Re: General Question re GRA Insurance
by Francesca Bronder
Good morning Justin,
I have noticed a different pattern depending if the GRA is a Master's level student or a Doctoral student. So I spoke with a someone from the Grad school and they told me that while Doctoral GRAs must receive 100% coverage in tuition and health insurance, the same is not required for Master's level GRA.
Doctoral student's health insurance is charged to the Fringes line, I see it all the time in the MFRs. The difference is that COS does not cover it so it is charged to the grant through fringes, not on the SNOAs, while in Engineering (for students in CAMEE) it is covered by the individual KCEID department. If accidentally a KCIED grant is charged the UTSHIP, the department will transfer the cost out
This does not happen for Master's level students. I only see a Worker's Comp as a fringe benefit, and if there is insurance covered in the SNOA, it is "lumped up" in the tuition because it is not listed separately, and the PI does not let me know if it is included in the amount.
This is why when I assist with proposal, some COS PIs with a limited budget adopt the 8% fringe benefit for Master's level, instead of the higher option for Doctoral GRAs.
I hope this answers your question.
Sincerely,
Francesca Bronder, M.A.
Research Administrator II - College Research Administration
College of Sciences
The University of Texas at San Antonio
One UTSA Circle
San Antonio, TX 78249-1644
BSE 1.638
Email: francesca.bronder(a)utsa.edu<mailto:francesca.bronder@utsa.edu>
http://research.utsa.edu<http://research.utsa.edu/>
From: Justin Marmolejo <Justin.Marmolejo(a)utsa.edu<mailto:Justin.Marmolejo@utsa.edu>>
Sent: Tuesday, February 25, 2025 8:29 AM
To: rowdy.research(a)lists.it.utsa.edu<mailto:rowdy.research@lists.it.utsa.edu>
Subject: [Rowdy.research] General Question re GRA Insurance
Hello everyone!
OSP received the following question in our inbox and I thought this would be better answered by this group. Can anyone provide any guidance from their respective experiences?
Question: For GRAs employed under a grant, how is their insurance paid/processed? Do they complete a SNOA for it since the GRA insurance is billed to ASAP/tuition and fees? Would the funds come out of the Tuition and Fees Budget or the Fringe budget?
Thanks,
Justin
1 year
General Question re GRA Insurance
by Justin Marmolejo
Hello everyone!
OSP received the following question in our inbox and I thought this would be better answered by this group. Can anyone provide any guidance from their respective experiences?
Question: For GRAs employed under a grant, how is their insurance paid/processed? Do they complete a SNOA for it since the GRA insurance is billed to ASAP/tuition and fees? Would the funds come out of the Tuition and Fees Budget or the Fringe budget?
Thanks,
Justin
1 year
